These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5653333)

  • 21. [On the evaluation of therapeutic effects in hypertension (described by the example of Guanoxan)].
    Siedek H; Klein K; Grübl M
    Munch Med Wochenschr; 1965 Oct; 107(43):2119-24. PubMed ID: 5899029
    [No Abstract]   [Full Text] [Related]  

  • 22. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
    Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
    Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electrolyte metabolism in patients with hypertensive disease treated with hyparez].
    Kashnir VS
    Vrach Delo; 1973 Jan; 1():16-9. PubMed ID: 4722276
    [No Abstract]   [Full Text] [Related]  

  • 24. [CLINICAL RESEARCH WITH A COMPOUND HYPOTENSIVE PREPARATION (MEBUTAMATE + 1-4 DIHYDRAZINOPHTHALAZINE + DIHYDROCHLOROTHIAZIDE + POTASSIUM)].
    LONGARETTI A; BELSITO F
    Gazz Med Ital; 1963 Aug; 122():236-9. PubMed ID: 14087542
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-hypertensive therapy in geriatrics].
    Mangano D
    Minerva Med; 1970 Apr; 61(29):1426-8. PubMed ID: 5446158
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical administration of hydralazin (Depressan) in essential and renal hypertension].
    Teichmann G; Harms R; Wedler B; Rohmann H
    Z Arztl Fortbild (Jena); 1972 Nov; 66(21):1112-6. PubMed ID: 4576549
    [No Abstract]   [Full Text] [Related]  

  • 27. [CLINICAL STUDY OF A NEW COMPLEX HYPOTENSIVE DRUG COMBINATION].
    SANCHETTI P; FAVERO S
    Gazz Med Ital; 1963 Aug; 122():242-6. PubMed ID: 14083041
    [No Abstract]   [Full Text] [Related]  

  • 28. Essential hypertension--effective therapy in private practice.
    Tanney H
    Rocky Mt Med J; 1969 Jun; 66(6):43-5. PubMed ID: 5807597
    [No Abstract]   [Full Text] [Related]  

  • 29. [Characteristics of the action of gemiton, adelfan and dopegit on cerebral circulation in arterial hypertension].
    Eninia GI; Smeltere ES; Godlevska MA; Uzulinia IP
    Klin Med (Mosk); 1984 Mar; 62(3):100-3. PubMed ID: 6716915
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative mass studies on alpha-methyldopa (Presinol), Sali-Presinol and Cyclazenine in hypertensives of various origin].
    Schubert R; Pasz T
    Verh Dtsch Ges Inn Med; 1965; 71():445-55. PubMed ID: 5339213
    [No Abstract]   [Full Text] [Related]  

  • 31. Malignant hypertension: clinical recognition and management.
    Woods JW
    Cardiovasc Clin; 1978; 9(1):311-20. PubMed ID: 667886
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evolution of the electrocardiogram of the hypertensive under hypotensive treatment].
    Miori R; Frezza M
    Folia Cardiol; 1965; 24(4):180-92. PubMed ID: 5897900
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of severe hypertension with a combination of Adelphane-Esidrex and guanethidine sulphate (Ismelin).
    Datey KK; Dalvi CP; Deshmukh SN
    J Assoc Physicians India; 1968 Apr; 16(4):219-23. PubMed ID: 5655886
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combined action of oxprenolol, hydrochlorothiazide and hydralazine in rats with metacorticoid induced hypertension].
    García Sacristán A
    Rev Clin Esp; 1980 Jun; 157(6):417-8. PubMed ID: 7414035
    [No Abstract]   [Full Text] [Related]  

  • 35. [What is reliable in the therapy of hypertension?].
    Bock KD
    Internist (Berl); 1970 Dec; 11(12):419-23. PubMed ID: 4924813
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of hypertensive states with a combination of alpha-methyldopa and a diuretic].
    Beretta R; Cassi E; Colombo A; De Paoli A; Marciandi C; Renzetti GA
    Clin Ter; 1982 Dec; 103(5):487-500. PubMed ID: 7160141
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in the hemodynamic indices of hypertension patients].
    Shvedenko LA; Parashchak AP; Iurkevich ST; Neporadnyĭ MD; Bigar' PV
    Vrach Delo; 1983 Apr; (4):76-9. PubMed ID: 6868543
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical evaluation of debrisoquin in the treatment of hypertension.
    Rosendorff C; Marsden CD; Cranston WI
    Arch Intern Med; 1968 Dec; 122(6):487-90. PubMed ID: 5721874
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical study of a new product with hypotensive action: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Novelli E; Grillo A
    Minerva Cardioangiol; 1973 Nov; 21(11):748-53. PubMed ID: 4776571
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes In myocardial contractile function and microcirculation in hypertension].
    Vakaliuk PM; Shvedenko LA; Iurkevich ST; Nikulin KE; Ilika VG
    Vrach Delo; 1982 Apr; (4):52-5. PubMed ID: 7101858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.